版本:
中国

BRIEF-FDA committee recommends approval of Pfizer's epoetin alfa biosimilar

May 25 Pfizer Inc:

* FDA Advisory Committee recommends approval of Pfizer's proposed biosimilar to Epogen®/Procrit® across all indications

* Has entered into an agreement with Vifor Pharma Inc for commercialization of its proposed epoetin alfa biosimilar in certain channels Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐